This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2004 Jul;364(9431):309-10.

doi: 10.1016/S0140-6736(04)16737-8.

Meningococcal conjugate vaccine in the UK: an update

Paul A Offit¹, Georges Peter

Affiliations

PMID: 15276371
DOI: 10.1016/S0140-6736(04)16737-8

Comment

Meningococcal conjugate vaccine in the UK: an update

Paul A Offit et al. Lancet. 2004 Jul.

. 2004 Jul;364(9431):309-10.

doi: 10.1016/S0140-6736(04)16737-8.

Authors

Paul A Offit¹, Georges Peter

Affiliation

¹ Division of Infectious Diseases, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA. offit@email.chop.edu

PMID: 15276371
DOI: 10.1016/S0140-6736(04)16737-8

No abstract available

PubMed Disclaimer

Comment on

Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction.
Trotter CL, Andrews NJ, Kaczmarski EB, Miller E, Ramsay ME. Trotter CL, et al. Lancet. 2004 Jul 24-30;364(9431):365-7. doi: 10.1016/S0140-6736(04)16725-1. Lancet. 2004. PMID: 15276396

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science